The slippery protein problem - Works in Progress Magazine
worksinprogress.co · 2,218 words · saved by 1 readers
A disease that was once a death sentence is increasingly treatable
For most of the last half-century, a diagnosis of metastatic pancreatic cancer was a death sentence. In December 2025, former Nebraska Senator Ben Sasse announced he had been diagnosed with stage four pancreatic cancer that had spread to his lungs, liver and other organs, and was given three to four months to live from the time of diagnosis. With little to lose, he enrolled in a clinical trial for an experimental drug. Four months later, he reported a 76 percent reduction in tumor volume, describing the drug, daraxonrasib, as a ‘miracle’. His face, ravaged by a severe skin rash from the treatm
saved by
related reading
- The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decadesstatnews.com
- The current state of the art and future trends in RAS-targeted cancer therapiesnature.com
- Weekly Dose of Optimism #208notboring.co
- Pancreatic Cancer - PMCncbi.nlm.nih.gov
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Cure all diseasesworksinprogress.news
- Pancreatic Cancer - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance - PMCncbi.nlm.nih.gov
- Targeting telomerase for cancer therapy | Oncogenenature.com
- Loss and revival of androgen receptor signaling in advanced prostate cancernature.com